Standard BioTools Pre-Paid Expenses 2010-2024 | LAB
Standard BioTools pre-paid expenses from 2010 to 2024. Pre-paid expenses can be defined as a current asset created by prepayment of costs and expenses for which the benefits will occur at a future date.
| Standard BioTools Annual Pre-Paid Expenses (Millions of US $) |
|
|---|---|
| 2024 | $9 |
| 2023 | $3 |
| 2022 | $4 |
| 2021 | $4 |
| 2020 | $4 |
| 2019 | $5 |
| 2018 | $2 |
| 2017 | $2 |
| 2016 | $3 |
| 2015 | $6 |
| 2014 | $2 |
| 2013 | $2 |
| 2012 | $1 |
| 2011 | $1 |
| 2010 | $2 |
| 2009 | $1 |
| Standard BioTools Quarterly Pre-Paid Expenses (Millions of US $) |
|
|---|---|
| 2024-12-31 | $9 |
| 2024-09-30 | $9 |
| 2024-06-30 | $10 |
| 2024-03-31 | $9 |
| 2023-12-31 | $3 |
| 2023-09-30 | $3 |
| 2023-06-30 | $4 |
| 2023-03-31 | $3 |
| 2022-12-31 | $4 |
| 2022-09-30 | $5 |
| 2022-06-30 | $6 |
| 2022-03-31 | $5 |
| 2021-12-31 | $4 |
| 2021-09-30 | $6 |
| 2021-06-30 | $7 |
| 2021-03-31 | $9 |
| 2020-12-31 | $4 |
| 2020-09-30 | $6 |
| 2020-06-30 | $4 |
| 2020-03-31 | $3 |
| 2019-12-31 | $5 |
| 2019-09-30 | $5 |
| 2019-06-30 | $4 |
| 2019-03-31 | $3 |
| 2018-12-31 | $2 |
| 2018-09-30 | $2 |
| 2018-06-30 | $3 |
| 2018-03-31 | $2 |
| 2017-12-31 | $2 |
| 2017-09-30 | $2 |
| 2017-06-30 | $5 |
| 2017-03-31 | $2 |
| 2016-12-31 | $3 |
| 2016-09-30 | $3 |
| 2016-06-30 | $4 |
| 2016-03-31 | $3 |
| 2015-12-31 | $6 |
| 2015-09-30 | $3 |
| 2015-06-30 | $3 |
| 2015-03-31 | $2 |
| 2014-12-31 | $2 |
| 2014-09-30 | $4 |
| 2014-06-30 | $3 |
| 2014-03-31 | $3 |
| 2013-12-31 | $2 |
| 2013-09-30 | $3 |
| 2013-06-30 | $2 |
| 2013-03-31 | $2 |
| 2012-12-31 | $1 |
| 2012-09-30 | $2 |
| 2012-06-30 | $2 |
| 2012-03-31 | $2 |
| 2011-12-31 | $1 |
| 2011-09-30 | $2 |
| 2011-06-30 | $1 |
| 2011-03-31 | $1 |
| 2010-12-31 | $2 |
| 2010-09-30 | $1 |
| 2010-06-30 | |
| 2010-03-31 | |
| 2009-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.399B | $0.174B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $39.307B | 54.29 |
| Hims & Hers Health (HIMS) | United States | $13.112B | 136.23 |
| Tempus AI (TEM) | United States | $10.781B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.503B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.415B | 68.98 |
| Privia Health (PRVA) | United States | $3.036B | 207.50 |
| Enovis (ENOV) | United States | $2.041B | 11.38 |
| Clover Health Investments (CLOV) | United States | $1.735B | 0.00 |
| Schrodinger (SDGR) | United States | $1.706B | 0.00 |
| Phreesia (PHR) | United States | $1.529B | 0.00 |
| Omnicell (OMCL) | United States | $1.315B | 23.21 |
| Azenta (AZTA) | United States | $1.223B | 56.83 |
| 10x Genomics (TXG) | United States | $1.125B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.610B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.569B | 0.00 |
| Talkspace (TALK) | United States | $0.500B | 149.50 |
| Veradigm (MDRX) | United States | $0.482B | 0.00 |
| Claritev (CTEV) | United States | $0.450B | 0.00 |
| TruBridge (TBRG) | United States | $0.368B | 816.67 |
| Health Catalyst (HCAT) | United States | $0.286B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.212B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.207B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.147B | 0.00 |
| Pulmonx (LUNG) | United States | $0.138B | 0.00 |
| American Well (AMWL) | United States | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.090B | 0.00 |
| CareCloud (CCLD) | United States | $0.086B | 3.27 |
| Outset Medical (OM) | United States | $0.070B | 0.00 |
| 111 (YI) | China | $0.067B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.059B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.032B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |